![Kinneret Livnat Savitzky](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kinneret Livnat Savitzky
Directeur/Membre du Conseil chez
Symbol Therapeutics Ltd.
Profil
Kinneret Livnat Savitzky is Director at Symbol Therapeutics Ltd. since 2021.
Ms. Savitzky is VP Biology & Business Development at Alphabiome Ltd. starting in 2026.
Former roles include CEO at BioLineRx Ltd. from 2010 to 2016, Chief Executive Officer at FutuRx Ltd. from 2017 to 2021, Director at Tau Ventures Ltd., General Manager at Bioline Innovations Jerusalem LP from 2004 to 2009, and Managing Partner at Team8 Labs Ltd. Education includes a doctorate from Tel-Aviv University conferred in 1997 and an undergraduate degree from The Hebrew University of Jerusalem conferred in 1990.
Postes actifs de Kinneret Livnat Savitzky
| Sociétés | Poste | Début |
|---|---|---|
Symbol Therapeutics Ltd.
 Symbol Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops novel immunoregulatory therapeutic protein | Directeur/Membre du Conseil | 29/12/2021 |
Anciens postes connus de Kinneret Livnat Savitzky
| Sociétés | Poste | Fin |
|---|---|---|
Tau Ventures Ltd.
 Tau Ventures Ltd. Investment ManagersFinance TAU Ventures invests in companies located in Israel. The firm focuses on sectors such as the technology sector. It provides financing for pre-seed and seed stage capital requirements with initial investment size ranging up to USD 1 million. It acts as a lead investor and makes follow-on investments. | Directeur/Membre du Conseil | 01/01/2026 |
FutuRx Ltd.
 FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Directeur Général | 01/01/2021 |
| BIOLINERX LTD. | Directeur Général | 01/10/2016 |
Bioline Innovations Jerusalem LP | Corporate Officer/Principal | 01/12/2009 |
Team8 Labs Ltd.
 Team8 Labs Ltd. Investment ManagersFinance Team8 Labs invests in companies located in Israel. The firm targets companies operating in the fields of cybersecurity, software infrastructure, fintech and digital health. It provides financing in the form of equity for seed and early stage capital requirements. | Private Equity Investor | - |
Formation de Kinneret Livnat Savitzky
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
86
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Tel-Aviv University
 Tel-Aviv University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioLineRx Ltd.
 BioLineRx Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes cell transplantation products | Health Technology |
Bioline Innovations Jerusalem LP | |
Team8 Labs Ltd.
Team8 Labs Ltd. Investment ManagersFinance Team8 Labs invests in companies located in Israel. The firm targets companies operating in the fields of cybersecurity, software infrastructure, fintech and digital health. It provides financing in the form of equity for seed and early stage capital requirements. | Finance |
FutuRx Ltd.
FutuRx Ltd. Investment ManagersFinance FutuRx invests in companies located in Israel. The firm focuses on sectors such as health technology and technology services with an investment size of ILS 3 million. It participates in seed stage transactions and also makes follow on investment. | Finance |
Tau Ventures Ltd.
Tau Ventures Ltd. Investment ManagersFinance TAU Ventures invests in companies located in Israel. The firm focuses on sectors such as the technology sector. It provides financing for pre-seed and seed stage capital requirements with initial investment size ranging up to USD 1 million. It acts as a lead investor and makes follow-on investments. | Finance |
Symbol Therapeutics Ltd.
Symbol Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Develops novel immunoregulatory therapeutic protein | Commercial Services |
Choisissez Zonebourse 
